Acutus Medical, Inc.
AFIB
$0.0538
$0.011828.10%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 15.37M | 12.16M | 9.55M | 7.17M | -3.55M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.37M | 12.16M | 9.55M | 7.17M | -3.55M |
| Cost of Revenue | 15.49M | 13.74M | 11.80M | 10.25M | -10.86M |
| Gross Profit | -119.00K | -1.58M | -2.25M | -3.09M | 7.31M |
| SG&A Expenses | 12.44M | 12.48M | 13.54M | 14.67M | -7.79M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.66M | 27.85M | 27.88M | 28.41M | -34.66M |
| Operating Income | -13.29M | -15.69M | -18.33M | -21.24M | 31.11M |
| Income Before Tax | -5.21M | -6.32M | -10.19M | -12.41M | 73.14M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.28 | -6.38 | -10.25 | -12.48 | 73.12 |
| Earnings from Discontinued Operations | -36.63M | -43.16M | -56.72M | -69.19M | -37.47M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -41.91M | -49.54M | -66.97M | -81.66M | -32.79M |
| EBIT | -13.29M | -15.69M | -18.33M | -21.24M | 31.11M |
| EBITDA | -13.25M | -15.57M | -18.14M | -21.05M | 27.03M |
| EPS Basic | -1.43 | -1.69 | -2.30 | -2.81 | -1.11 |
| Normalized Basic EPS | -0.35 | -0.38 | -0.45 | -0.46 | 0.66 |
| EPS Diluted | -1.43 | -1.69 | -2.30 | -2.81 | -0.78 |
| Normalized Diluted EPS | -0.35 | -0.38 | -0.45 | -0.46 | 0.81 |
| Average Basic Shares Outstanding | 118.31M | 117.77M | 117.09M | 116.16M | 115.54M |
| Average Diluted Shares Outstanding | 118.31M | 117.77M | 117.09M | 116.16M | 124.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
